EPOR and anemia (phenotype): In addition, although EpoR agonists drugs are initially aimed at treating anemia, it is starting to demonstrate the sign of pleiotropic effects for treating a wide range of complex disorders, including CVD, neurodegenerative disorders, spinal cord injury, and diabetic retinopathy (Sanchis-Gomar et al., 2013).